ArticleJournal of diabetes science and technology2024
Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction.
Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus.BMC endocrine disorders · 2026Pooled it
- Type 1 diabetes-specific distress among adults with type 1 diabetes in Japan.Journal of diabetes investigation · 2026Article
- "It is not a disease like cancer, we can live well with diabetes" - A qualitative study exploring positive experiences of diabetic patients.Journal of family medicine and primary care · 2025Article
- Clinical Usage and Potential Benefits of a Continuous Glucose Monitoring Predict App.Journal of diabetes science and technology · 2024Article
- Predicting Glucose Values: A New Era for Continuous Glucose Monitoring.Journal of diabetes science and technology · 2024Article
- Concept and Implementation of a Novel Continuous Glucose Monitoring Solution With Glucose Predictions on Board.Journal of diabetes science and technology · 2024Article
- The Promise of Hypoglycemia Risk Prediction.Journal of diabetes science and technology · 2024Article
- Enhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App.Journal of diabetes science and technology · 2024Article
- Correlation Analysis of Hypoglycemic Fear and Psychological Well-Being and Family Support Function in Older Adults Diabetic Patients.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExtended glucose predictions are novel in diabetes management. Currently, there is no solution widely available. People with diabetes mellitus (DM) are offered features like trend arrows and limited predictions linked to predefined situations. Thus, the impact of extended glucose predictions on the burden of diabetes and person-reported outcomes (PROs) is unclear.
methodsIn this online survey, 206 people with type 1 and type 2 diabetes (T1D and T2D), 70.9% and 29.1%, respectively, who participated in the dia·link online panel and were current continuous glucose monitoring (CGM) users, were presented with different scenarios of hypothetical extended glucose predictions. They were asked to imagine how low glucose predictions of 30 minutes and overnight as well as glucose predictions up to 2 hours would influence their diabetes management. Subsequently, they completed the Hypoglycemia Fear Survey II (HFS-II) and the T1 Diabetes Distress Scale (T1-DDS) by rating each item on a 5-point scale (-2: strong deterioration to +2: strong improvement) according to the potential change due to using glucose predictions.
resultsFor all glucose prediction periods, 30 minutes, up to 2 hours, and at nighttime, the surveyed participants expected moderate improvements in both fear of hypoglycemia (HFS-II: 0.57 ± 0.49) and overall diabetes distress (T1-DDS = 0.44 ± 0.49). The T1-DDS did not differ for type of therapy or diabetes.
conclusionsPeople with T1D and T2D would see glucose predictions as a potential improvement regarding reduced fear of hypoglycemia and diabetes distress. Therefore, glucose predictions represent a value for them in lowering the burden of diabetes and its management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.